Correction: Nephrology: What You May Have Missed in 2023.

In the article by AlHabobi and colleagues ([1]), a reader identified a typographical error in the section "What is the main message for physicians who are not nephrology specialists?" under "The potassium binder patiromer also reduces serum phosphorus levels." The article stated that among 86 participants with baseline hyperphosphatemia, the mean reduction in serum phosphorus levels after 4 weeks of treatment was 0.7 mEq/L; this should instead be 0.62 mg/dL. The text has been corrected. [Extracted from the article]